Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPK13 | O15264 | 4/20 | 0.45 |
| ▸ | MAPK12 | P53778 | 4/20 | 0.45 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.45 |
| ▸ | GCGR | P47871 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | RAF1 | P04049 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14059756 | 0.92 | MAPK13 (0.50) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL14060383 | 0.89 | MAPK14 (0.51) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL31305402 | 0.89 | MAPK14 (0.46) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL14059685 | 0.89 | MAPK14 (0.46) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL14060006 | 0.88 | MAPK14 (0.52) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL14060521 | 0.87 | MAPK14 (0.53) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL14060077 | 0.86 | PNP (0.38) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL31305395 | 0.86 | MAPK14 (0.40) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL14060537 | 0.86 | MAPK14 (0.40) | KDM4EHPGDSMN1; SMN2MAPK13MAPK12 | |
| SCHEMBL14060207 | 0.86 | PNP (0.43) | KDM4EHPGDSMN1; SMN2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215572-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4506488-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | Shikoku Chemicals Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| CN-118922584-A | Surface treating agent for copper or copper alloy | 四国化成工业株式会社 | 2024-11-08 | — | — | CN | disclosed |
| WO-2023190263-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | 四国化成工業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2019-08-27 | — | — | US | disclosed |
| US-20170064823-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2017-03-02 | — | — | US | disclosed |
| US-9532493-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| CN-103547706-B | Surface treatment composition for copper and copper alloy and use thereof | 四国化成工业株式会社 | 2016-09-28 | — | — | CN | disclosed |
| EP-2714962-B1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEM (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-20140097231-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2014-04-10 | — | — | US | disclosed |
| WO-2012161341-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2012-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SOD1, SOD3, AOC3 | KDM4E 3649/4885HPGD 1126/4885SMN1; SMN2 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.